A detailed history of Artal Group S.A. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 2,519,841 shares of TNGX stock, worth $14.9 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
2,519,841
Previous 2,194,841 14.81%
Holding current value
$14.9 Million
Previous $17.4 Million 24.06%
% of portfolio
1.37%
Previous 0.94%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.66 - $10.15 $2.16 Million - $3.3 Million
325,000 Added 14.81%
2,519,841 $21.6 Million
Q1 2024

May 13, 2024

BUY
$7.51 - $12.88 $16.5 Million - $28.3 Million
2,194,841 New
2,194,841 $17.4 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $521M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.